Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)

The summary for the Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional): This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.

Federal Grant Title:	Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education, Food and Nutrition, Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-MD-24-006
Type of Funding:	Grant
CFDA Numbers:	93.121, 93.233, 93.286, 93.307, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.866
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 9th, 2026
Original Application Deadline:	December 9th, 2026
Posted Date:	March 8th, 2024
Creation Date:	March 8th, 2024
Archive Date:	January 14th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	March 8th, 2024

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-006.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional); • Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in La...; • Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional); • Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional); • Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatme...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • NCI Pathway to Independence Award (K99/R00 Clinical Trial Required); • Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Opt...; • Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R2...; • Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional); • Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)